Key papers in Urology
Pofolia’s corpus holds 63 papers from the Urology subfield (2012–2023). The list below starts with the most cited.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”.
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
Urologia Internationalis · 2013 · Q2 · FWCI 40.10 · 4,544 citations · Open access
Tadalafil monotherapy significantly improves lower urinary tract symptoms (LUTS) and erectile dysfunction in men with benign prostatic hyperplasia (BPH), with the 5mg dose specifically enhancing maximal urinary flow rate.
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
The Journal of Urology · 2016 · Q1 · SJR 2.00 · FWCI 64.06 · 1,946 citations
A new 7-question symptom index for benign prostatic hyperplasia (BPH) has been developed and validated, demonstrating strong reliability and accuracy in distinguishing BPH patients from controls.
The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society
Neurourology and Urodynamics · 2015 · Q2 · FWCI 116.99 · 1,521 citations
The International Children's Continence Society (ICCS) has released an updated terminology document for lower urinary tract (LUT) function in children and adolescents, reflecting advancements in knowledge over the past seven years.
Principles and methods of preparation of platelet-rich plasma: A review and author′s perspective
Journal of Cutaneous and Aesthetic Surgery · 2014 · Q3 · FWCI 22.11 · 1,011 citations
This review addresses the confusion surrounding platelet-rich plasma (PRP) terminology, preparation protocols, and characterization, highlighting the need for standardization in its application across dermatology.
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
International Journal of Molecular Sciences · 2020 · Q1 · SJR 1.00 · FWCI 85.79 · 950 citations · Open access
Platelet-rich plasma (PRP) therapy, utilizing autologous cellular therapies, shows potential for tissue repair in musculoskeletal disorders, osteoarthritis, and chronic wounds by leveraging platelet growth factors.
Correction: Corrigendum: Assembling Composite Dermal Papilla Spheres with Adipose-derived Stem Cells to Enhance Hair Follicle Induction
Scientific Reports · 2016 · Q1 · 941 citations · Open access
This corrigendum corrects errors in the affiliations of a previously published article concerning the assembly of composite dermal papilla spheres with adipose-derived stem cells for hair follicle induction.
Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management
Journal of Tissue Engineering · 2018 · Q1 · SJR 1.00 · FWCI 77.75 · 890 citations · Open access
This review highlights common bone substitutes, detailing their characteristics and clinical applications, while identifying limitations in managing large defects and achieving central vascularization.
The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction
Neurourology and Urodynamics · 2019 · Q2 · FWCI 71.09 · 815 citations
A new consensus-based terminology report has been developed by the International Continence Society (ICS) to standardize definitions for adult male lower urinary tract and pelvic floor symptoms and dysfunction.
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment
The Journal of Urology · 2015 · Q1 · SJR 2.00 · FWCI 75.81 · 786 citations
This guideline amendment provides an updated evidence-based framework for diagnosing and treating non-neurogenic overactive bladder (OAB) in adults, incorporating literature up to October 2018.
Treatment With Platelet-Rich Plasma Is More Effective Than Placebo for Knee Osteoarthritis
The American Journal of Sports Medicine · 2013 · Q1 · SJR 2.00 · FWCI 63.15 · 763 citations
A single injection of platelet-rich plasma (PRP) significantly improved symptoms of early knee osteoarthritis compared to a saline placebo, with results lasting up to six months.
The Standardization of Terminology of Lower Urinary Tract Function in Children and Adolescents: Update Report from the Standardization Committee of the International Children's Continence Society
The Journal of Urology · 2014 · Q1 · SJR 2.00 · FWCI 82.59 · 727 citations
The International Children's Continence Society (ICCS) has released an updated terminology document to reflect current knowledge and advancements in understanding lower urinary tract function and dysfunction in children and adolescents.
A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification
Skin Appendage Disorders · 2017 · Q2 · FWCI 34.14 · 724 citations · Open access
This review synthesizes current knowledge on Platelet-Rich Plasma (PRP), a biological product derived from a patient's own blood with elevated platelet concentration, to aid clinicians in understanding and applying this therapy.
Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors
Stem Cell Research & Therapy · 2013 · Q1 · SJR 1.00 · FWCI 24.62 · 717 citations · Open access
A new, reproducible method for preparing platelet-rich plasma (PRP) consistently yields 5.4- to 7.3-fold increased platelet concentrations with high purity, enabling standardized growth factor quantification for regenerative therapies.
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
The Journal of Urology · 2012 · Q1 · SJR 2.00 · FWCI 51.90 · 709 citations
This guideline provides a clinical framework for diagnosing and treating non-neurogenic overactive bladder (OAB) in adults, outlining evidence-based first through third-line treatments.
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment
The Journal of Urology · 2015 · Q1 · SJR 2.00 · FWCI 47.73 · 699 citations
This amendment updates the AUA guideline for diagnosing and treating Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by incorporating new literature published since 2011.
Advanced Platelet-Rich Fibrin: A New Concept for Cell-Based Tissue Engineering by Means of Inflammatory Cells
Journal of Oral Implantology · 2014 · Q2 · FWCI 17.57 · 658 citations · Open access
Advanced Platelet-Rich Fibrin (A-PRF), achieved with lower centrifugation speed and longer time, shows an enhanced presence of neutrophilic granulocytes in the distal part of the clot compared to standard PRF (S-PRF). This altered cell distribution may influence macrophage differentiation and subsequently enhance bone and soft tissue regeneration.
International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure‐flow study
Neurourology and Urodynamics · 2016 · Q2 · FWCI 38.17 · 655 citations
The International Continence Society (ICS) has updated its 'Good Urodynamic Practice' standards, introducing ICS-GUP2016. This revision clarifies over 30 terms and establishes new guidelines for the practice, quality control, interpretation, and reporting of urodynamic studies.
Platelet‐Rich Plasma: A Milieu of Bioactive Factors
Arthroscopy The Journal of Arthroscopic and Related Surgery · 2012 · Q1 · SJR 2.00 · FWCI 31.98 · 608 citations
Platelet-rich plasma (PRP) contains more than just platelets, including leukocytes, erythrocytes, and various bioactive factors that influence musculoskeletal tissue regeneration and healing.
Platelet‐Rich Plasma: The PAW Classification System
Arthroscopy The Journal of Arthroscopic and Related Surgery · 2012 · Q1 · SJR 2.00 · FWCI 23.99 · 606 citations
A new PAW classification system is proposed to standardize the comparison and replication of platelet-rich plasma (PRP) preparation protocols and results in orthopaedic research.
Alopecia Areata
New England Journal of Medicine · 2012 · Q1 · SJR 18.00 · FWCI 26.22 · 577 citations
This review synthesizes current knowledge on hair follicle biology and the underlying pathobiology of alopecia areata, a common condition causing hair loss.
Recently added
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023
The Journal of Urology · 2023 · Q1 · SJR 2.00 · FWCI 110.85 · 439 citations
The 2023 AUA Guideline amendment updates recommendations for BPH/LUTS management, incorporating new evidence on combination therapy, PVP, WVTT, laser enucleation, PAE, and adding a new statement on TIPD.
Two Phase 3 Trials of Baricitinib for Alopecia Areata
New England Journal of Medicine · 2022 · Q1 · SJR 18.00 · FWCI 85.11 · 471 citations · Open access
In two Phase 3 trials (n=1200), 4-mg oral baricitinib achieved significant hair regrowth in severe alopecia areata patients, with 38.8% (BRAVE-AA1) and 35.9% (BRAVE-AA2) reaching a SALT score of <=20 at 36 weeks, compared to 6.2% and 3.3% for placebo.
Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis
JAMA · 2021 · Q1 · SJR 5.00 · FWCI 57.74 · 420 citations · Open access
Intra-articular platelet-rich plasma (PRP) injections did not significantly improve knee pain or medial tibial cartilage volume compared to saline placebo in patients with mild to moderate knee osteoarthritis over 12 months.
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
Journal of Cosmetic Dermatology · 2021 · Q1 · FWCI 44.65 · 391 citations
A review of androgenetic alopecia (AGA) treatments highlights that while topical minoxidil, oral finasteride, and low-level light therapy are FDA-approved, a broader range of options exist, including PRP and exosome treatments, necessitating careful patient-specific consideration of efficacy, side effects, compliance, and cost.
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management
The Journal of Urology · 2021 · Q1 · SJR 2.00 · FWCI 59.07 · 387 citations
The AUA's revised guideline provides evidence-based recommendations for the initial work-up and medical management of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) in aging men.
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app